PROGRESSION‐FREE SURVIVAL FOLLOWING LENALIDOMIDE‐BASED TREATMENT IS SIGNIFICANTLY LONGER IN EXTRAGASTRIC THAN IN GASTRIC MARGINAL ZONE B‐CELL LYMPHOMA OF THE MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA). (June 2017)